Lemaitre Vascular Inc revenue
Lemaitre Vascular Inc's revenue was $250m in fiscal 2025, up 13.5% on the year before. Since fiscal 2009 ($50.9m) it has grown at a compound 10.4% a year. Over the last twelve months it was $262m.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51 | 56 | 58 | 57 | 65 | 71 | 78 | 89 | 101 | 106 | 117 | 129 | 154 | 162 | 193 | 220 | 250 | 262 |
| Growth on the year before | — | +10.1% | +2.9% | −1.6% | +13.8% | +10.1% | +10.2% | +13.8% | +13.1% | +4.7% | +11.0% | +10.4% | +19.4% | +4.7% | +19.7% | +13.6% | +13.5% | — |
| Gross profit | 37 | 42 | 40 | 41 | 45 | 48 | 54 | 63 | 71 | 74 | 80 | 85 | 101 | 105 | 127 | 151 | 179 | 191 |
| Gross margin | 73.3% | 74.4% | 69.7% | 72.0% | 69.9% | 68.1% | 69.1% | 70.6% | 70.1% | 70.0% | 68.1% | 65.4% | 65.7% | 64.9% | 65.7% | 68.6% | 71.5% | 72.9% |
Where the revenue comes from
| Region | Revenue | YoY |
|---|---|---|
| Americas | $160M | ▲ 10.4% |
| United States | $142M | ▲ 10.0% |
| EMEA | $73.1M | ▲ 21.9% |
| Other Countries | $61.7M | ▲ 18.4% |
| Germany | $17.9M | ▲ 24.1% |
| Asia Pacific | $16.8M | ▲ 9.8% |
| Canada | $15.3M | ▲ 11.6% |
| United Kingdom | $13.2M | ▲ 20.6% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Lemaitre Vascular Inc's 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Lemaitre Vascular Inc | $262m | 11.8% | 14.0% |
| Orthopediatrics Corp | $264m | 16.1% | 23.0% |
| Axogen, Inc. | $267m | 24.3% | 20.6% |
| Cerus Corp | $254m | 74.6% | 89.8% |
| Establishment Labs Holdings Inc. | $246m | 38.6% | 11.5% |
| Skinhealth Systems Inc. | $290m | -6.5% | -9.5% |
Compare with peers
- Orthopediatrics Corp revenue
- Axogen, Inc. revenue
- Cerus Corp revenue
- Establishment Labs Holdings Inc. revenue
- Skinhealth Systems Inc. revenue
Head to head: KIDS vs LMATAXGN vs LMATCERS vs LMATESTA vs LMAT
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies